Consistent with these bioinformatic predictions, our HepG2–T cell co‐culture assays demonstrated that DCAF7 knockout markedly enhanced CD8+ T cell‐mediated cytotoxicity and IFN‐γ secretion, providing functional evidence that DCAF7 restrains anti‐tumour immune activity within the TME. The gene discussed is CD8A; the disease is neoplasm.